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Abstract. 
 
Bax is a member of the Bcl-2 family of pro-
teins known to regulate mitochondria-dependent pro-
grammed cell death. Early in apoptosis, Bax translocates
from the cytosol to the mitochondrial membrane. We
have identiﬁed by confocal and electron microscopy a
novel step in the Bax proapoptotic mechanism immedi-
ately subsequent to mitochondrial translocation. Bax
leaves the mitochondrial membranes and coalesces into
large clusters containing thousands of Bax molecules
that remain adjacent to mitochondria. Bak, a close ho-
mologue of Bax, colocalizes in these apoptotic clusters
in contrast to other family members, Bid and Bad,
which circumscribe the outer mitochondrial membrane
throughout cell death progression. We found the forma-
tion of Bax and Bak apoptotic clusters to be caspase in-
dependent and inhibited completely and speciﬁcally by
Bcl-X
 
L
 
, correlating cluster formation with cytotoxic ac-
tivity. Our results reveal the importance of a novel
structure formed by certain Bcl-2 family members dur-
ing the process of cell death.
Key words: apoptosis • Bcl-2 • green ﬂuorescent pro-
tein • mitochondria • clusters
 
Introduction
 
Apoptosis is a regulated mechanism to selectively eliminate
unwanted cells, keeping the delicate balance between cell
proliferation and death. Cell death stimuli induce the acti-
vation of cell executioners, a family of cysteine proteases
called caspases. Mitochondria-dependent and -independent
pathways activate these caspases that subsequently lead to
cell death. The mitochondria-dependent pathway is regu-
lated by the Bcl-2 family of proteins. Bcl-2 was discovered
to be a protooncogene that inhibited cell death induced by
interleukin 3 deprivation (Vaux et al., 1988) and was
shown subsequently to inhibit death induced by many
other stimuli. The Bcl-2 family consists of two opposing
clans: one subfamily including Bcl-2, Bcl-X
 
L
 
, Ced-9, Bcl-w,
and Mcl-1 that promotes cell survival and another that
promotes cell death. The proapoptotic subfamily can be
further divided into those proteins consisting of Bcl-2 ho-
mology (BH)
 
1 
 
1–3, like Bax, Bak, and Bok, and those con-
sisting of only the BH3 region, like Bad, Bid, Bik, Bim,
and Hrk (Adams and Cory, 1998).
One of the intriguing aspects of apoptosis regulation by
members of the Bcl-2 family is their subcellular localiza-
tion and translocation. Certain pro- and antiapoptotic
members such as Bcl-2, Bcl-X
 
L
 
, and Bak reside predomi-
nantly in the mitochondria, whereas other members such
as Bax, Bid, and Bad reside in the cytosol of healthy cells.
Early during the initiation of apoptosis, these cytosolic
Bcl-2 family members translocate to the outer mitochon-
drial membrane (Gross et al., 1999a). After translocation
of Bax and Bid to mitochondria, mitochondria lose their
membrane potential (
 
  
 
m) and release intermembrane
space proteins. However, the mechanisms linking proap-
optotic Bcl-2 family members to these subsequent events
in apoptosis are unclear.
Translocation of these proapoptotic proteins involves
distinct mechanisms. Phosphorylation and 14-3-3 binding
(Zha et al., 1996b) regulate Bad translocation, whereas
Bid is regulated by caspase 8 cleavage as part of the Fas
signaling pathway (Li et al., 1998; Luo et al., 1998). The
regulation of Bax translocation is different from that of
Bad and Bid but little understood. Bax translocation in-
volves a conformational change that exposes the NH
 
2
 
 ter-
minus and a hydrophobic COOH terminus that targets mi-
tochondria (Gross et al., 1998; Nechushtan et al., 1999). It
has also been suggested that Bid binds to cytosolic Bax to
initiate this change in conformation and targeting of mito-
chondria (Desagher et al., 1999).
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Translocation of Bax to mitochondria has been linked to
the release of the mitochondrial intermembrane protein,
cytochrome c, to the cytosol (Eskes et al., 1998; Jurgens-
meier et al., 1998; Pastorino et al., 1998), and the question
of how Bax might participate in this process is of current
interest. Bax was shown to act as a pore-forming protein
(Antonsson et al., 1997; Schlesinger et al., 1997; Eskes et
al., 1998) and has also been suggested to interact with the
voltage-dependent anion channel (VDAC) (Narita et al.,
1998) or adenine nucleotide transporter (ANT) (Marzo et
al., 1998). VDAC and ANT, the two most abundant pro-
teins of the outer and inner mitochondrial membranes (re-
spectively) are components of the permeability transition
pore complex thought to be involved in cytochrome c
 
 
 
re-
lease. On the other hand, other studies have indicated that
the cytochrome c release pathway can be uncoupled from
the mitochondrial permeability transition pore and Bax
(Eskes et al., 1998; Jurgensmeier et al., 1998; Kim et al.,
2000). Current hypotheses about the function of Bax as-
sume that the critical site of Bax activity is the mitochon-
dria. In this study, we show that Bax resides in the mito-
chondria only during a brief period in the process of
apoptosis. After this period, Bax leaves the mitochondria
and coalesces into clusters that are adjacent to the mito-
chondria. In addition, our observations indicate that clus-
ter formation may be essential for Bax and Bak promotion
of cell death. These findings provide a new framework for
understanding the roles of Bax and Bak in the cell death
program.
 
Materials and Methods
 
Restriction and modifying enzymes and oligonucleotide primers were ob-
tained from GIBCO BRL. DNA sequencing was performed with a Seque-
nase II kit (United States Biochemical Corp.). All of the media and antibi-
otics were obtained from Biofluid, Inc. Except as noted, reagents were
purchased from Sigma-Aldrich.
 
Generation of Expression Constructs
 
Wild-type full-length Bax, Bcl-X
 
L
 
, full-length and truncated Bid, and full-
length Bad were synthesized by a standard PCR using as templates the
cDNA for human 
 
Bax
 
 and mouse 
 
Bid
 
 (a gift from S.J. Korsmeyer, Har-
vard Medical School, Boston, MA), the cDNA for human 
 
Bcl-X
 
L
 
 (a gift
from C. Thompson, University of Pennsylvania, Philadelphia, PA), and
the cDNA for mouse 
 
Bad
 
 (a gift from M.E. Greenberg, Harvard Medical
School, Boston, MA). The primers used in the amplification reactions in-
troduced an XhoI site for the NH
 
2
 
 terminus and an EcoRI site for the
COOH terminus of the Bax and Bad. The EcoRI site for the NH
 
2
 
 termi-
nus and a BamHI site for the COOH terminus were introduced in the am-
plifications of full-length and truncated Bid. All PCR reactions were done
by 30 cycles of 1 min at 94
 
 
 
C, 2 min at 60
 
 
 
C, and 3 min at 72
 
 
 
C using Pfu
polymerase (Stratagene). The resulting PCR products were digested with
the appropriate restriction enzymes and cloned into the mammalian ex-
pression vectors, ECFP-C1 for Bax, EYFP-N1 for Bid, and EYFP-C1 for
Bcl-X
 
L
 
 and Bad. All vectors were purchased from CLONTECH Labora-
tories, Inc. The yellow fluorescent protein (YFP) fusion to the mutated
COOH terminus of Bax, lacking serine 184 (YFP-20) in EYFP-C1, and
the full-length point mutant Bax-S184V in ECFP-C1 (CLONTECH Labo-
ratories, Inc.) were cloned as described previously (Nechushtan et al.,
1999). Human VDAC-1 (a gift from Michael Forte, Vollum Institute, Ore-
gon Health Sciences University, Portland, OR) was cloned into the
DsRed vector (CLONTECH Laboratories, Inc.). Cytochrome c–green
fluorescent protein (GFP) was a kind gift from Anna-Liisa Nieminen
(Case Western Reserve University, Cleveland, OH). All constructs were
confirmed by restriction endonuclease digestion and DNA sequence anal-
ysis. 
 
Escherichia
 
 
 
coli
 
 strain DH5
 
 
 
 (Stratagene) was used for all plasmid
transformations and propagations.
 
Cloning of Human Bak cDNA
 
RNA was extracted and isolated from hepatocellular carcinoma Hep G2
cells using RNA Iso-lator (Genosys Biotechnology). RNA (2 mg) was re-
verse transcribed to a single strand of cDNA using reverse primers and
Moloney murine leukemia virus reverse transcriptase. Bak cDNA was
amplified using the forward primer 5
 
 
 
-TCAGATCTCGAGCTATGGCT-
TCGGGGCAAGGCCC-3
 
 
 
 and the reverse primer 5
 
 
 
-ACTGCAGAAT-
TCTCATGATTTGAAGAATCTTCGTACC-3
 
 
 
, introducing XhoI and
EcoRI sites, respectively. PCR was performed using a PerkinElmer Cetus
thermal cycler in a volume of 100 
 
 
 
l by 30 cycles of 1 min at 94
 
 
 
C, 2 min at
60
 
 
 
C, and 2 min at 72
 
 
 
C using Pfu polymerase (Stratagene). The resulting
PCR product was digested with XhoI and EcoRI and cloned into the
mammalian expression vector EYFP-C1 (CLONTECH Laboratories,
Inc.). The resulting YFP-Bak construct was confirmed by restriction endo-
nuclease digestion and DNA sequence analysis.
 
Cell Culture and Measurement of Cell Viability
 
Cos-7 green monkey renal epithelial, HeLa human cervical carcinoma,
and Hep G2 hepatocellular carcinoma cell lines (American Type Culture
Collection) were grown in DME (Cos-7) and Earle’s minimum essential
medium (HeLa and Hep G2), each supplemented with 10% heat-treated
FCS, 2 mM glutamine, nonessential amino acids, 2.5 mM sodium pyru-
vate, 100 U/ml penicillin, and 100 
 
 
 
g/ml streptomycin. Cells were cultured
at 37
 
 
 
C in 5% CO
 
2
 
.
To evaluate the ability of Bcl-X
 
L
 
 to counter Bak and Bax mutant induc-
tion of apoptosis of cells in culture, we used luciferase assay as described
previously (Nechushtan et al., 1999). In short, the mammalian expression
vector pGL3 (Promega) carrying the firefly luciferase (
 
Luc
 
) structural
gene was cotransfected along with either Bak or Bax mutant S184V (Ne-
chushtan et al., 1999) with or without the antiapoptosis protein Bcl-X
 
L
 
. A
4:16:1 molar ratio of the tested gene to Bcl-X
 
L
 
 or control DNA plasmid
and 
 
Luc
 
 were used to cotransfect Cos-7 cells in 6-well tissue culture. 24 h
after transfection, the cells were washed with PBS and harvested using the
luciferase assay system (Promega). Luciferase activity was measured by
liquid scintillation counting using 20 
 
 
 
l of the cellular extract. In every ex-
periment, each sample was repeated six times, and cell viability is shown
as the relative luc activity of the tested construct.
 
Transfection of Cells in Culture
 
For confocal microscopy, 10
 
4
 
 cells were plated on a 2-well Lab-Tek cham-
bered coverglass (Nunc). For the EM, 5 
 
 
 
 10
 
3
 
 cells were plated on a 4-well
Lab-Tek permanox chamber slide (Nunc), and both were transfected 48 h
later using 1 
 
 
 
g plasmid DNA and 3 
 
 
 
l of FuGENE 6 (Roche) per cham-
ber for the confocal microscopy and half of the amount for the EM.
 
Confocal Microscopy
 
Confocal microscope images of live Cos-7 and HeLa cells were captured
on an LSM 510 microscope with a 60 
 
 
 
 1.3 NA Apochromat objective
(ZEISS). Cells were grown and transfected as described above on 1 thick-
ness 2-well Lab-Tek chambered coverglass (Nunc). After 24–48 h, confo-
cal microscopy of live cells was performed after incubation with 20 ng/ml
of a mitochondrion-specific dye (Mitotracker red CMXRos; Molecular
Probes, Inc.) as indicated in individual experiments. The excitation wave-
length for cyan fluorescent protein (CFP), GFP, YFP, and Mitotracker
red CMXRos were 413, 488, 514, and 543 nm, respectively. The pH was
maintained by addition of 25 mM Hepes, pH 7.4, to the culture medium.
 
Quantitation of Bax Molecules 
in the Apoptotic Clusters
 
Cos-7 cells were transfected with enhanced GFP (EGFP)-Bax as de-
scribed above. Confocal microscope images were captured on an LSM 510
(ZEISS) microscope using 488 nm laser excitation for EGFP with low in-
tensity illumination (2% laser power). Images for quantitation of Bax
cluster fluorescence were captured with a 60
 
 
 
 1.4 NA Apochromat objec-
tive (ZEISS) and an open pinhole to collect fluorescence from the entire
depth of the cell. Estimation of the number of Bax molecules in the apop-
totic clusters was made by comparing the total fluorescence in a cluster
with a standard curve calculated from a serial dilution of recombinant
EGFP protein (CLONTECH Laboratories, Inc.). 10–15 clusters were
measured in each cell, and 10 different cells were analyzed including
healthy ones. Background fluorescence was measured in four different re- 
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gions in each tested cell in areas of the cytosol free of clusters, and the av-
erage background value was subtracted from the fluorescence values mea-
sured from the apoptotic clusters. The analysis of the confocal images was
done using MetaMorph (Universal Imaging Corp.).
 
Thin Section Immunoelectron Microscopy
 
Preembedding immunocytochemistry was performed as described previ-
ously (Tanner et al., 1996). In brief, samples were fixed with 2% parafor-
maldehyde and 0.1% glutaraldehyde in 0.1 M phosphate buffer at pH 7.4
for 30 min, washed, permeabilized, and incubated with one of the follow-
ing antibodies: antiuniversal Bax 6A7 and the anti–human Bax 1F6 mono-
clonal antibodies, both recognize monkey Bax (Hsu and Youle, 1997); and
for all GFP variants, 3E6 anti-AFP was used (Quantum). Treatment of
samples with the secondary antibody conjugated to Nanogold (Nano-
probes) was followed by washing and silver enhancement (HQ kit; Nano-
probes). Samples were treated with 0.2% OsO
 
4
 
, dehydrated, and embed-
ded in Epoxy resin.
 
Results
 
Bax Leaves the Mitochondria and Clusters 
during Apoptosis
 
The translocation of Bax to the outer mitochondrial mem-
brane is an early step in apoptosis. Translocation is associ-
ated with a conformational change that exposes the NH
 
2
 
terminus and a hydrophobic portion of the COOH termi-
nus. This 21–amino acid portion of the COOH terminus
alone, minus serine 184, targets the mitochondria in both
healthy and dying cells (Nechushtan et al., 1999). When we
compared the localization of wild-type Bax fused to CFP-
Bax and the COOH-terminal fragment fused to YFP-20,
we were surprised to find that the two proteins colocalize
on the outer mitochondrial membrane only during a brief
period after induction of apoptosis. As apoptosis pro-
ceeds, YFP-20 remains, circumscribing the mitochondrial
membrane (Fig. 1 and Fig. 2 A), whereas CFP-Bax coa-
lesces into clusters (Fig. 1). The clusters are small initially
(
 
 
 
0.5 
 
 
 
m) but progressively enlarge and remain closely
associated with mitochondria. Each mitochondrion ap-
pears to be associated with one to three of the clusters, and
some clusters appear to be shared between two to three
mitochondria (Fig. 1, enlargement).
Previous work suggested that Bax forms oligomers dur-
ing apoptosis (Oltvai et al., 1993; Sedlak et al., 1995; Tan et
al., 1999; Antonsson et al., 2000; Saito et al., 2000), but the
sizes of the Bax apoptotic clusters we observed were too
large for them to represent individual dimers, tetramers,
or even 30-mers as had been suggested. To assess the num-
ber of Bax molecules in single clusters, we employed a
quantitative fluorescence imaging technique. Confocal mi-
croscope images of GFP-Bax–expressing cells were com-
pared with images taken of serial dilutions of commercial
recombinant GFP under the same conditions (as described
in Materials and Methods). A typical concentration of
GFP-Bax molecules measured in the cytosol of healthy
cells was 4 
 
 
 
M. Our calculations indicated that the number
of Bax molecules in the apoptotic clusters ranged from 1 
 
 
 
10
 
3
 
 to 2 
 
  
 
10
 
4
 
 molecules. These values are likely to under-
estimate the numbers of molecules because they are based
on the assumption that each cluster was contained in a sin-
gle 0.8-
 
 
 
m optical section, which was true for some small
clusters but not for large ones. Thus, the novel structures
we have found associated with mitochondria in apoptotic
cells contain several thousands of Bax molecules.
To further characterize the large Bax clusters identified
by confocal microscopy, we examined healthy and apop-
totic cells by preembedding electron microscopic immuno-
cytochemistry. We examined cells transfected with GFP-
Bax or Bax alone and nontransfected cells. The cells were
treated with staurosporine (STS), a broad specificity ki-
nase inhibitor used extensively to trigger apoptosis (Weil
et al., 1996), and were fixed at a time when Bax was clus-
tered in a high percentage of the cells as determined in
cells expressing GFP-Bax. Inspection of the cultures after
they were embedded in plastic showed that some of the
apoptotic cells were lost during processing, reducing the
percentage of apoptotic cells relative to healthy cells. In
immunolabeled cultures examined by EM, we observed
cells in which Bax was cytosolic (Fig. 2 B), Bax was uni-
formly distributed around the surfaces of mitochondria
(Fig. 2 C), and Bax was clustered at sites adjacent to mito-
chondria (Fig. 2, D–I). We interpret the third group to rep-
resent cells in which Bax appeared clustered by light
microscopy. The Bax clusters were not enclosed in mito-
chondrial membranes, which were clearly delineated de-
spite some disruption of inner mitochondrial structure
(Fig. 2 F). Although Bax initially coated the mitochondria
membranes as seen in Fig. 2 C when Bax coalesced into
clusters, most of the outer mitochondrial membranes were
cleared of all detectable Bax (Fig. 2, D–I).
Clustering of Bax was detected with two different mono-
clonal anti-Bax antibodies: 1F6 that recognizes human and
monkey Bax and 6A7 that recognizes the Bax protein
from mice, rats, monkeys, cows, and humans (Fig. 2, D–G
and I) and with a monoclonal anti-GFP antibody, 3E6
anti-AFP, that recognizes all GFP variants (Fig. 2 H). All
three antibodies showed the same pattern of Bax cluster-
ing in mitochondria-associated structures in apoptotic
cells. One of the two antibodies we used to detect Bax,
6A7, only binds to Bax that has undergone a conforma-
tional change associated with translocation from the cyto-
sol to the mitochondria (Hsu and Youle, 1998; Nechushtan
et al., 1999). The binding of this antibody to the clusters
(Fig. 2 I) indicates that the clusters contain an activated
form of Bax.
Clustering of Bax was not a consequence of overexpres-
sion because clusters were observed in nontransfected ap-
optotic cells (Fig. 2 D); nor was it GFP-related aggregation
since cells overexpressing wild-type Bax showed the same
clustering (Fig. 2, E and F) as GFP-Bax (Fig. 2, G–I). The
number of silver particles per cluster was smaller in non-
transfected cells than in cells overexpressing Bax, indicat-
ing that there were fewer Bax molecules per cluster.
We reported previously that the Bax protein, even when
overexpressed well beyond the endogenous level, would
translocate completely from the cytosol to the mitochon-
dria (Nechushtan et al., 1999). We concluded at that time
that there must be unlimited binding sites for Bax on the
mitochondria. The present finding of large apoptotic clus-
ters of Bax provides an alternative explanation for this
complete translocation. These clusters serve as the final
target for the translocating Bax, making the number of mi-
tochondria binding sites irrelevant. It is of note that both
Bax clusters and monomers were never found to be associ- 
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ated with any other membranes or organelles, such as the
nucleus or ER, by either confocal microscopy or EM.
 
Bak Colocalizes with Bax in the Apoptotic 
Clusters whereas Bid and Bad Do Not
 
Among the proapoptotic members of the Bcl-2 family,
Bak is closest to Bax in terms of sequence homology, size
(Adams and Cory, 1998), and biological activity. Studying
mice lacking both Bax and Bak genes (bax
 
 
 
/
 
 
 
 bak
 
 
 
/
 
 
 
)
showed overlapping roles of these proteins in the regula-
tion of apoptosis (Lindsten et al., 2000). Like Bax, Bak has
been shown to induce the loss of mitochondrial membrane
potential and lead to cytochrome c release, whereas Bcl-2
and Bcl-X
 
L
 
 prevent these events (Eskes et al., 1998;
Shimizu et al., 1999; Chatterjee et al., 2000; Wei et al.,
2000). However, Bax exists in the cytosol of healthy cells
and translocates to the mitochondria during apoptosis,
whereas Bak constitutively resides on mitochondrial mem-
branes in healthy cells. To determine whether Bak forms
similar clusters during apoptosis, cells were cotransfected
with CFP-Bak and either YFP-20 as a marker for mito-
chondria or YFP-Bax to visualize Bax apoptotic clusters.
Bak is located on mitochondria in healthy cells and fully
colocalizes with YFP-20 (Fig. 3 A, top row) in contrast to
Bax, which resides in the cytosol (Fig. 3 B, top row, second
panel). However, upon induction of apoptosis by STS, Bak
segregates from YFP-20 and the mitochondria and coa-
lesces into mitochondria-associated clusters (Fig. 3 A, bot-
tom row). These clusters have the same characteristics as
those formed by Bax in terms of size, location, and num-
ber. Bak and Bax colocalize in the same clusters adjacent
to mitochondria during apoptosis (Fig. 3 B, bottom row,
overlay). The localization of Bak and Bax is significantly
different from that of the mitochondria (Fig. 3 B, bottom
row, overlay, blue staining). To further investigate these
apoptotic clusters of Bak revealed by the fluorescence im-
ages of living cells, we examined Cos-7 cells expressing
CFP-Bak using EM (Fig. 3). Bak circumscribes the outer
mitochondrial membrane in healthy cells (Fig. 3 C, con-
trol) and coalesces in large multimeric clusters in apop-
totic ones (Fig. 3 C, STS). The number and distribution of
the Bak clusters are similar to those found for Bax (Fig. 2).
Bid and Bad structurally resemble Bax and Bak only in
their BH3 domain (Gross et al., 1999a), and like Bax they
are cytosolic in healthy cells and translocate to mitochon-
dria during apoptosis (Zha et al., 1996b; Li et al., 1998).
These resemblances led us to ask whether Bid and Bad co-
alesce in clusters along with Bax and Bak. We cotrans-
fected Cos-7 cells with Bid-YFP or YFP-Bad and CFP-
Bax. In apoptotic cells, Bid-YFP and YFP-Bad did not
colocalize with Bax clusters but instead remained circum-
scribing the mitochondria (Fig. 4). Thus, two BH3-only
members of the Bcl-2 family, Bid and Bad, do not coalesce
during apoptosis in contrast to Bax and Bak. Interestingly,
over-expressed Bid and Bad, unlike Bax, do not translo-
cate completely to the mitochondria in apoptotic cells. In-
stead, a significant portion of the cellular Bid and Bad re-
mains in the cytosol. The Bcl-2 family member Bid is
cytosolic in healthy cells and translocates to mitochondria
during an early stage of apoptosis (Li et al., 1998; Luo et
al., 1998). Several groups reported that after cleavage by
Figure 1. Bax coalesces adjacent to mitochondria during apoptosis. Cos-7 and HeLa cells transiently expressing CFP-Bax together
with the outer mitochondrial membrane marker, YFP-20, were treated with 1  M STS for 5 h to induce apoptosis and then were exam-
ined by laser scanning confocal microscopy. CFP-Bax (red) was located in small punctate structures, whereas YFP-20 (green) was lo-
cated in larger round mitochondrial-shaped structures. In overlay images, the Bax clusters appeared to be located next to or on top of
the YFP-20–labeled structures. Bars, 25  m. 
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caspase 8, Bid triggers Bax redistribution from cytosol to
membrane (Eskes et al., 1998; Jurgensmeier et al., 1998;
Desagher et al., 1999; Gross et al., 1999b). Interestingly,
when we compared the time course of Bid and Bax trans-
location from cytosol to mitochondria during STS-induced
apoptosis in cells coexpressing both proteins we found that
often Bax translocation differed from that of Bid. In some
cells, Bax translocated to the mitochondria before Bid. In
other cells, Bax and Bid translocation was simultaneous or
Bid translocation preceded that of Bax (data not shown),
indicating that although Bax and Bid migrate to mitochon-
dria in approximately the same time frame, it is unlikely
that Bid serves as a direct activator of Bax translocation.
To determine whether other proteins involved in mito-
chondria-dependent apoptosis might coalesce into clusters
with Bax and Bak, we examined by confocal microscopy
Cos-7 cells transfected with cytochrome c–GFP or DsRed-
VDAC. In apoptotic cells (STS treatment), VDAC re-
mained in the mitochondria, whereas cytochrome c be-
came cytosolic (data not shown) as shown previously by
others (Liu et al., 1996; Kluck et al., 1997). Therefore, it is
most likely that VDAC and cytochrome c are not part of
the Bax and Bak apoptotic clusters.
To determine whether cluster formation is caspase de-
pendent, we induced apoptosis while inhibiting caspase ac-
tivation with benzyloxycarbonyl-Val-Ala-Asp-(OMe)-flu-
oromethylketone (zVAD-fmk), a tetrapeptide inhibitor of
caspases that prolongs the induction of apoptosis induced
by various agents (Dolle et al., 1994). We cotransfected
CFP-Bax or CFP-Bak with the mitochondria marker YFP-
20 in the presence of 50 
 
 
 
M zVAD-fmk and treated those
cells with STS. As can be seen in Fig. 5, both CFP-Bax and
Figure 2. Ultrastructural localization of Bax and YFP-20. (A) Silver-enhanced immunogold labeling of YFP-20 in apoptotic Cos-7 cells
showed specific labeling of gold particles around the outer mitochondria membrane. (B) Healthy Cos-7 cells transfected with wild-type
Bax show a cytosolic diffuse distribution of Bax. (C) An early stage of apoptosis showing cytosolic and mitochondria-bound wild-type
Bax labeling. (D) Apoptotic nontransfected cells showing labeling of endogenous Bax clusters. (E and F) Apoptotic cells transfected
with wild-type Bax. The bottom micrograph in F shows a 4  enlargement of the contact site between the Bax cluster and the mitochon-
dria. (G–I) Apoptotic cells transfected with GFP-Bax. In A and H, cells were labeled with 3E6 monoclonal anti-GFP (all variants), B–G
were labeled with 1F6 monoclonal anti–human Bax, and I was labeled with 6A7 monoclonal anti-universal Bax. In STS-treated samples
(all panels except A and B), the diffuse labeling of Bax in the cytoplasm is greatly diminished, whereas mitochondria-associated clusters
of various sizes appear. Bars: (A) 1  m; (C–J) 0.5  m. 
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CFP-Bak formed mitochondria-associated clusters similar
to those formed without the treatment of caspase inhibitor
(Figs. 1–3). These results place Bax and Bak translocation
and cluster formation during apoptosis upstream of the
caspase activation or caspase independent.
 
Bcl-X
 
L
 
 Blocks Bax and Bak Clustering and Toxicity
but Does Not Prevent Constitutive Outer 
Mitochondrial Membrane Localization
 
Bcl-X
 
L
 
 has been shown to inhibit apoptosis induced by dif-
ferent stimuli in various cell types. Bcl-X
 
L
 
 prevents the cell
death induced by overexpression of Bax or Bak and re-
duces the rate of cell loss during STS treatment (Chit-
tenden et al., 1995; Vander Heiden et al., 1997; Wolter et
al., 1997; Griffiths et al., 1999). Furthermore, Bcl-X
 
L
 
 does
not require a direct interaction with Bax to inhibit its pro-
motion of cell death (Cheng et al., 1996). To analyze the
biological significance of cluster formation, we asked what
effect Bcl-X
 
L
 
 might have on this process. Bcl-X
 
L
 
 is known
to inhibit Bax translocation to mitochondria during apop-
tosis (Wolter et al., 1997). Thus, to specifically test the role
of Bcl-X
 
L
 
 on cluster formation we focused on Bax-S184V
because this protein constitutively associates with mito-
chondria. The S184V mutant form of Bax is constitutively
targeted to the mitochondria in healthy cells and has a
proapoptotic activity similar to wild-type Bax (Nechushtan
et al., 1999). We have found that, like Bax, Bax-S184V also
forms mitochondrial-associated clusters in apoptotic cells
(Fig. 6 A). When we coexpressed Bax-S184V and Bcl-X
 
L
 
in Cos-7 cells, we found that Bcl-X
 
L
 
 completely prevented
the cluster formation of the Bax mutant with or without
treatment of STS (Fig. 6 B). Cells cotransfected with Bcl-
X
 
L
 
 and Bax-S184V showed a marked reduction in apopto-
sis compared with cells singly transfected with Bax-S184V
(Fig. 7 A). CFP-Bax-S184V targeted the mitochondria re-
gardless of the absence or presence of overexpressed YFP-
Bcl-X
 
L
 
, showing that Bcl-X
 
L
 
 does not inhibit the mito-
chondria-binding step (Fig. 7 C). However, the presence of
Bcl-X
 
L
 
 completely inhibited coalescence into clusters as is
observed in cells singly transfected with Bax (Fig. 1) or
Bax-S184V (Fig. 6 A). Analysis of CFP-Bcl-X
 
L
 
 showed
that during apoptosis, Bcl-X
 
L
 
 always circumscribes the mi-
tochondria (data not shown). Bak, like Bax-S184V, is
bound to mitochondria in healthy cells. Cotransfection of
Bcl-X
 
L
 
 and Bak caused no change in Bak localization (Fig.
7 D). However, when apoptosis was induced by incubation
with STS, no Bak cluster formation occurred (data not
shown) as occurs in the absence of Bcl-X
 
L
 
 (Fig. 3).
Cotransfection with Bcl-X
 
L
 
 also markedly inhibited Bak-
stimulated apoptosis (Fig. 7 B). Furthermore, analysis of
CFP-Bcl-X
 
L
 
 showed that Bcl-X
 
L
 
 always circumscribes the
 
Figure 3.
 
Bak clusters and colocalizes with Bax in dying cells.
Healthy and apoptotic Cos-7 cells transiently coexpressing CFP-
Bak with either YFP-20 (A) or YFP-Bax (B) were examined by
laser scanning confocal microscopy. Bak (red) was associated
with mitochondria in healthy cells (control) and formed clusters
adjacent to mitochondria labeled with YFP-20 (green). Bak had a
distinctive distribution from Bax in healthy cells (B, control) but
colocalized with Bax in dying cells (B, STS). Mitochondria were
labeled with Mitotracker red CMXRos in B (blue). (C) Silver-
enhanced immunogold labeling of CFP-Bak in Cos-7 cells show-
ing specific labeling of gold particles around the mitochondria
outer membrane in healthy cells (control) and in large clusters
associated with the mitochondria in apoptotic cells (STS). Apop-
tosis was induced by addition of 1 
 
 
 
M STS for 5 h. Bars: (A and
B) 25 
 
 
 
m; (C) 0.5 
 
 
 
m.
Figure 4. Bid and Bad do not localize with Bax apoptotic clusters. Cos-7 cells transiently coexpressing CFP-Bax (red) with Bid-YFP or
YFP-Bad (green) were treated with 1  M STS for 5 h to induce apoptosis and visualized by laser fluorescence confocal microscopy. Bid
and Bad were localized in structures with shapes typical of mitochondria in dying cells at stages when Bax was localized in clusters. The
magnified image ( 5) shows parts of the same fields. Apoptosis was induced by addition of 1  M STS for 5 h. Bar, 25  m. 
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Figure 5. Bax and Bak clustering is caspase independent. Transient coexpression of CFP-Bax or CFP-Bak and YFP-20 in apoptotic
Cos-7 cells shows that mitochondria-associated clusters of Bax and Bak form in the presence of 50  M zVAD-fmk. The transfected cells
were treated with 1  M STS for 5 h and visualized by laser scanning confocal microscopy. Both Bax and Bak coalesce into mitochon-
dria-associated clusters (red) different from YFP-20 (green) that remains on the outer mitochondrial membrane. Bars, 25  m.
Figure 6. Bcl-XL inhibits the formation of apoptotic clusters of the constitutive mitochon-
dria-docking Bax mutant, S184V. (A) Transient expression of CFP–Bax-S184V and YFP-
20 in apoptotic Cos-7 cells shows the formation of mitochondria-associated clusters by the
S184V Bax mutant. (B) Quantitation of Bax-S184V cluster formation. Cos-7 cells were
transfected with Bax-S184V, with or without Bcl-XL, and two of the groups were treated
with 1  M STS for 6 h. 150 cells in each treatment group were examined for the presence of
clusters under the confocal microscope. Results are displayed as the percentage of cells with
clusters of the total cells counted. This experiment was repeated four times. 
Nechushtan et al. 
 
Kilomeric Clusters of Bax
 
1273
 
mitochondria in the presence of either Bax-S184V or Bak
(Fig. 7, C and D) and remains on the mitochondria during
apoptosis (data not shown). The observation that Bcl-X
 
L
 
specifically blocks cluster formation and the bioactivity of
Bax-S184V and Bak indicates that the clusters are the bio-
logically active proapoptotic structures.
 
Discussion
 
Bax redistributes from the cytosol to the mitochondria
(Hsu et al., 1997; Wolter et al., 1997) and undergoes con-
formational changes during the early stages of apoptosis
(Hsu and Youle, 1998; Desagher et al., 1999; Nechushtan
et al., 1999). Recent studies have suggested three main
models for the Bax mechanism of activating apoptosis af-
ter mitochondrial insertion: Bax may neutralize antiapop-
totic members of the Bcl-2 family (Yin et al., 1994; Han et
al., 1996; Zha et al., 1996a), bind and regulate mitochon-
drial proteins like VDAC (Narita et al., 1998) and ANT
(Marzo et al., 1998), or act as a pore-forming protein by
homooligomerization to release apoptosis activating fac-
tors (Antonsson et al., 1997, 2001; Schlesinger et al., 1997;
Eskes et al., 1998; Mikhailov et al., 2001). All of these mod-
els place Bax across the mitochondria membranes at the
end of apoptotic activation. Our present results indicates
that targeting the mitochondrial membranes is only the
first step (Fig. 8) in the Bax mechanism of action and that
it is essential that Bax complete a second step, coalescing
into apoptotic clusters, during cell death. Bak, which re-
sides in the mitochondrial membranes of healthy cells,
shares this second step as it coalesces into the same apop-
totic clusters upon cell death.
Overexpression of Bcl-X
 
L
 
 specifically blocks Bax and Bak
cluster formation and prevents cell death, indicating that the
clusters are required for death to occur. When GFP–wild-
type Bax was coexpressed with Bcl-X
 
L
 
 and apoptosis was in-
duced, neither docking of GFP-Bax to the mitochondria nor
clustering could be detected (Wolter et al., 1997). The model
that Bcl-X
 
L
 
 inhibits cluster formation merely by blocking
Bax docking to mitochondria cannot explain the Bcl-X
 
L
 
 in-
hibition of Bax-S184V and Bak clustering, since they reside
in the mitochondrial membrane before apoptosis. Overall,
our data suggest that the inhibition of Bax clustering (step 2)
by Bcl-X
 
L 
 
somehow inhibits the docking of Bax on the outer
mitochondrial membrane (step 1). Previously, we and others
have assumed that Bax insertion to the mitochondria was a
critical event in the progress of apoptosis (Goping et al.,
1998; Murphy et al., 2000). However, there are reports that
Bax inserts into mitochondria membrane in cells that remain
healthy (Desagher et al., 1999). Bax was also reported to un-
dergo a rapid translocation to mitochondria as cells were de-
tached from the extracellular matrix and returned to the cy-
tosol upon reattachment (Gilmore et al., 2000). This short
time redistribution to the mitochondria did not result in
commitment to apoptosis and cell death, possibly due to the
Bcl-X
 
L
 
 antiapoptotic effect of inhibiting cluster formation
(Fig. 8, block of step 2). We predict that the Bax that can
bind mitochondria in healthy cells coats the outer mitochon-
drial membrane, awaiting an apoptotic triggering signal, and
does not form the apoptotic clusters.
The ability of Bcl-X
 
L to block Bax and Bak apoptosis
promotion through inhibition of cluster formation ad-
dresses one of the fundamental questions involving the op-
posing biological activities of members of the Bcl-2 family.
It is still not established if Bax activity promotes cell death
and Bcl-XL inhibits Bax or if Bcl-XL actively promotes cell
viability and Bax inhibits Bcl-XL. Aside from their oppos-
ing apoptotic activity, Bax, Bak, and Bcl-XL are very simi-
lar. Bax and Bcl-XL have similar three-dimensional struc-
tures (Suzuki et al., 2000), and both form channels in lipid
bilayers (Minn et al., 1997; Schlesinger et al., 1997). The
formation of the large mitochondria-associated clusters is
one of the few distinguishing molecular differences be-
tween Bax and Bcl-XL. Our data indicate that Bcl-XL in-
hibits Bax cluster formation and apoptosis induction.
These results are consistent with the model that Bax,
through cluster formation, is actively inducing cell death,
and Bcl-XL is the inhibitor.
Since initially described, the role of Bax dimerization
has been subject to debate. The rheostat model in which
the ratio of Bax homodimers to the heterodimers with Bcl-2
determines survival or death was proposed originally
(Oltvai et al., 1993). However, other studies showed that
cytosolic Bax is a monomer (Hsu and Youle, 1997, 1998).
Since then, various studies have proposed different nu-
merical associations among Bax molecules during apopto-
sis. Antonsson et al. (2001), for example, suggested that
the channel-forming Bax oligomer is composed of six to
eight Bax molecules. Another study showed that the num-
ber of Bax molecules that participate in the active mem-
brane pore increases in a concentration-dependent man-
ner up to a maximum of four molecules (Saito et al., 2000).
In the present study, the EM and fluorescent microscopy
were unable to detect small complexes like dimers or tet-
ramers; however, complexes of thousands of GFP-Bax
molecules were found in cells undergoing apoptosis.
Both electron microscope data and fluorescent intensity
show a variation in the sizes of the Bax apoptotic clusters.
Our analysis of fluorescent images of GFP-Bax compared
with GFP recombinant protein in solution indicates that
the clusters contain on the order of several thousands to
several tens of thousands of GFP-Bax molecules. Since the
clusters grow as cell death progresses, small clusters may
exist at early stages in apoptosis, but these would be diffi-
cult to discern because of the presence of cytosolic GFP-
Bax at this stage. Considering the size of the apoptotic
clusters and their localization outside the mitochondria
with only a small proportion of the total molecules in con-
tact with the outer membrane (Fig. 2, D–I), it may be pos-
sible to purify the Bax clusters. However, different centrif-
ugation techniques, including sucrose gradients, were unable
to separate the clusters from the mitochondria without dis-
persing Bax into soluble small molecular weight forms
(our unpublished data).
Bax undergoes conformational changes during apopto-
sis (Hsu and Youle, 1998; Desagher et al., 1999; Nechush-
tan et al., 1999). The S184V Bax mutant when already
docked to mitochondria does not expose the 6A7 epitope,
and like the wild-type Bax it exposes that epitope during
apoptosis (Nechushtan et al., 1999). Our EM studies show
that the 6A7 epitope is exposed in the Bax clusters (Fig. 2
I). Similarly, Bak exposes its NH2 terminus during apopto-
sis (Griffiths et al., 1999). Thus, it appears that the confor-
mational change in Bax and Bak is an obligatory step inThe Journal of Cell Biology, Volume 153, 2001 1274Nechushtan et al. Kilomeric Clusters of Bax 1275
the mitochondria-associated clusters formation and apop-
tosis induction. Our data showing that Bak takes part in
the same apoptotic clusters as Bax may indicate a coopera-
tive action with Bax. On the other hand, Bax and Bak may
represent either a back up and/or parallel system in which
one protein can substitute for the other, or one in which
the proteins are similar tools triggered by different stimuli/
pathways in the execution of the cell death program.
Surprisingly, proapoptotic Bid and Bad do not form ap-
optotic clusters and continue to coat the mitochondria of
dying cells. This suggests that Bid and Bad have a funda-
mentally different mechanism of cell death promotion. At
this stage, we can only speculate on the mechanism of Bax
and Bak mode of action. Whether it is the autonomous
function of the apoptotic clusters that contributes to the
mitochondrial dysfunction or the actual clustering and de-
parture of proapoptotic proteins from the outer mitochon-
drial membrane, the significance of the clusters to the ap-
optotic process has been introduced.
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